雅思备考如何提升阅读效率

由 范文百科 分享时间：2024-06-05 15:54:13 加入收藏我要投稿点赞

雅思复习备考，考生需要学习的内容很多，不过大多数考生的复习时间很有限，不是那么充裕，难免有遗漏的知识。下面，小编就为大家带来了雅思阅读备考效率提升攻略，快来学习下吧!

雅思备考如何提升阅读效率?

有的考生会一次次地祈祷：“希望这次考试不要有选择题或段落细节信息定位题!”这样做，其实是无形中给自己制造了负面的影响。考试题型不是我们所能预料和控制的，一旦有了上述心理，很有可能一看到题型就慌了，一开始就没有一个好的状态。

其次，考生必须对各类题型的题型特点和答题注意事项了如指掌。

考生除了要有一定的词汇量和阅读速度之外，常见的雅思阅读技巧和解题策略是必须的。而解题策略很多时候是建立在考生熟悉题型特点的基础之上的。

比如说，考生拿到一篇文章绝不是从第1题接到13题，而是应该分析各组题型的特点和难易，由易到难。

同样，考生也可以根据3篇各自的题型来初步判断哪一篇的题型可能对自己比较有利，哪篇可能较难，以便能灵活地采取合适的策略。

最后，考生在考前进行学习时，不要只做模式套题，而应该多做些雅思专题的练习，了解总结自己没什么把握的题型。

注意训练时时侯的掌控是很重要的，不要让自己在半小时内只完成6道是非题，那样不能达到雅思考试最好的训练目的，不能保证雅思集体训练良好的效果。

掌握了这三个建议，大家就可以在备考雅思阅读考试的时候有更好的一个准则可以遵守了。掌握备考的方法对于雅思阅读考试来说尤为重要，尤其是从从心理上和题型上进行两手准备。

以上就是关于雅思阅读备考效率提升攻略的相关内容，希望能给大家的考试带来帮助。希望同学们在备考雅思的过程中找到适合自己的方法，迅速提升自身雅思水平，最后顺利通过考试。

雅思阅读模拟练习及答案

1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib， a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients， a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. “There have been no red flags to my knowledge，” says John Chapman， a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. “This cancellation came as a complete shock.”

4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs， which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically， torcetrapib blocks a protein called cholesterol ester transfer protein (CETP)， which normally transfers the cholesterol from high-density lipoproteins to low density， plaque-promoting ones. Statins， in contrast， mainly work by lowering the ’bad’ low-density lipoproteins.

Under pressure

5. Researchers are now trying to work out why and how the drug backfired， something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation， it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

6. But it is also possible that the whole idea of blocking CETP is flawed， says Moti Kashyap， who directs atherosclerosis research at the VA Medical Center in Long Beach， California. When HDLs excrete cholesterol in the liver， they actually rely on LDLs for part of this process. So inhibiting CETP， which prevents the transfer of cholesterol from HDL to LDL， might actually cause an abnormal and irreversible accumulation of cholesterol in the body. “You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway，” says Kashyap.

Going up

7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug， called niacin， is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by， for example， introducing synthetic HDLs. “The only thing we know is dead in the water is torcetrapib， not the whole idea of raising HDL，” says Michael Miller， director of preventive cardiology at the University of Maryland Medical Center， Baltimore.

Questions 1-7

This passage has 7 paragraphs 1-7.

Choose the correct heading for each paragraph from the list of headings below

Write the correct number i-ix in boxes 1-7 on your answer sheet.

List of Headings

i. How does torcetrapib work?

ii. Contradictory result prior to the current trial

iii. One failure may possibly bring about future success

iv. The failure doesn’t lead to total loss of confidence

v. It is the right route to follow

vi. Why it’s stopped

vii. They may combine and theoretically produce ideal result